These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23826822)

  • 21. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
    Nerome Y; Imanaka H; Nonaka Y; Takei S
    Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
    Miyagi R; Ideguchi H; Soga T; Yamakawa Y; Otsuki H; Niino H; Shiina T; Ueda A; Ishigatsubo Y
    Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor necrosis factor blockers in rheumatoid arthritis.
    Pisetsky DS
    N Engl J Med; 2000 Mar; 342(11):810-1. PubMed ID: 10717018
    [No Abstract]   [Full Text] [Related]  

  • 24. Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept.
    Takatori S; Kamata Y; Murosaki T; Iwamoto M; Minota S
    J Rheumatol; 2010 Jan; 37(1):210-1. PubMed ID: 20040649
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee].
    Horneff G; Forster J; Seyberth HW; Michels H;
    Z Rheumatol; 2000 Dec; 59(6):365-9. PubMed ID: 11201000
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
    Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Higuchi R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
    Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM; Laxer RM; Babyn PS; Doria AS
    J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis.
    De Sanctis S; Marcovecchio ML; Gaspari S; Del Torto M; Mohn A; Chiarelli F; Breda L
    J Rheumatol; 2013 Jun; 40(6):943-8. PubMed ID: 23547210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
    Mikhail M; Weinberg JM; Smith BL
    Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
    [No Abstract]   [Full Text] [Related]  

  • 31. The TREAT study - trial or tribulation?
    Lehman TJ
    J Rheumatol; 2014 Jun; 41(6):1038-9. PubMed ID: 24882847
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of rheumatoid arthritis with etanercept.
    Genovese MC; Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept improves active polyarticular juvenile rheumatoid arthritis.
    Martini A
    Clin Exp Rheumatol; 2001; 19(2):122-4. PubMed ID: 11326472
    [No Abstract]   [Full Text] [Related]  

  • 35. Atrial fibrillation occurring in a patient taking etanercept plus methotrexate for rheumatoid arthritis.
    Wooten MD; Reddy GV; Johnson RD
    Del Med J; 2000 Dec; 72(12):517-9. PubMed ID: 11200291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trials reveal promising options for treating juvenile rheumatoid arthritis.
    Hampton T
    JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
    [No Abstract]   [Full Text] [Related]  

  • 37. Pediatric rheumatology: JIA, treatment and possible risk of malignancies.
    Ruperto N; Martini A
    Nat Rev Rheumatol; 2011 Jan; 7(1):6-7. PubMed ID: 21135880
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
    Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
    J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Etanercept].
    Kameda H
    Nihon Rinsho; 2013 Jul; 71(7):1214-7. PubMed ID: 23961669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.
    Southwood TR; Foster HE; Davidson JE; Hyrich KL; Cotter CB; Wedderburn LR; Hull RG; Venning HE; Rahman JK; Cummins CL;
    Rheumatology (Oxford); 2011 Jan; 50(1):189-95. PubMed ID: 21047801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.